These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 24954322)

  • 21. [Optical coherence tomographic analysis of in-stent neoatherosclerosis in lesions with restenosis after drug-eluting stent implantation].
    Liu ZJ; Shi B; Deng CC; Xu GX; Zhao RZ; Shen CY; Wang ZL; Liu HL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2018 Jan; 46(1):44-49. PubMed ID: 29374937
    [No Abstract]   [Full Text] [Related]  

  • 22. Dynamic neointimal pattern after drug-eluting stent implantation defined by optical coherence tomography.
    Yamamoto E; Xing L; Higuma T; Minami Y; Bryniarski K; Zanchin T; Wang Z; Aguirre AD; Lee H; Jang IK
    Coron Artery Dis; 2017 Nov; 28(7):557-563. PubMed ID: 28704243
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Difference in neointimal appearance between early and late restenosis after sirolimus-eluting stent implantation assessed by optical coherence tomography.
    Ino Y; Kubo T; Kitabata H; Ishibashi K; Tanimoto T; Matsuo Y; Shimamura K; Shiono Y; Orii M; Komukai K; Yamano T; Yamaguchi T; Hirata K; Tanaka A; Mizukoshi M; Imanishi T; Akasaka T
    Coron Artery Dis; 2013 Mar; 24(2):95-101. PubMed ID: 23363984
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neointimal patterns obtained by optical coherence tomography correlate with specific histological components and neointimal proliferation in a swine model of restenosis.
    Kim JS; Afari ME; Ha J; Tellez A; Milewski K; Conditt G; Cheng Y; Hua Yi G; Kaluza GL; Granada JF
    Eur Heart J Cardiovasc Imaging; 2014 Mar; 15(3):292-8. PubMed ID: 24022066
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of neointimal coverage and extra-stent lumen between sirolimus and everolimus-eluting stent using optical coherence tomography.
    Oda T; Okamura T; Yamada J; Miyagi N; Uehara H; Nao T; Tateishi H; Maeda T; Nakamura T; Shiraishi K; Nakashima T; Nishimura S; Miura T; Matsuzaki M; Yano M
    Heart Vessels; 2016 Apr; 31(4):449-56. PubMed ID: 25614415
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Longitudinal Neointimal Distribution Pattern After Everolimus-Eluting Stent Implantation: Insights From Optical Coherence Tomography Study.
    Curio J; Hioki H; Brugaletta S; Gomez-Lara J; Romaguera R; Cequier A; Herrera R; Jiménez-Quevedo P; Otsuki S; Masotti M; Sabaté M
    Cardiovasc Revasc Med; 2021 May; 26():17-23. PubMed ID: 33160894
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natural history of low-intensity neointimal tissue after an everolimus-eluting stent implantation: a serial observation with optical coherence tomography.
    Shibuya M; Fujii K; Fukunaga M; Imanaka T; Miki K; Tamaru H; Ohyanagi M; Masuyama T
    Heart Vessels; 2015 Jan; 30(1):136-9. PubMed ID: 24374577
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serial assessment of vessel interactions after drug-eluting stent implantation in unprotected distal left main coronary artery disease using frequency-domain optical coherence tomography.
    Fujino Y; Attizzani GF; Bezerra HG; Wang W; Tahara S; Yamamoto H; Chamie D; Kanaya T; Mehanna E; Takagi K; Nakamura S; Costa MA
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1035-45. PubMed ID: 24156964
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optical coherence tomographic comparison of neointimal coverage between sirolimus- and resolute zotarolimus-eluting stents at 9 months after stent implantation.
    Kim JS; Kim JS; Shin DH; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
    Int J Cardiovasc Imaging; 2012 Aug; 28(6):1281-7. PubMed ID: 21858655
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In-stent restenosis assessed with frequency domain optical coherence tomography shows smooth coronary arterial healing process in second-generation drug-eluting stents.
    Kajiya T; Yamaguchi H; Takaoka J; Fukunaga K; Arima R; Miyamura A; Ninomiya T; Atsuchi N; Atsuchi Y; Terashima M; Kaneda H; Ohishi M
    Singapore Med J; 2019 Jan; 60(1):48-51. PubMed ID: 29632955
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of post-stent irregular protrusion and subsequent neointimal characteristics between second- and third-generation drug-eluting stent implantation.
    Miura T; Sonoda S; Sanuki Y; Naka Y; Okabe H; Setoyama K; Inoue K; Shimizu A; Anai R; Tsuda Y; Araki M; Otsuji Y
    J Cardiol; 2020 Nov; 76(5):464-471. PubMed ID: 32636130
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optical coherence tomography-based evaluation of in-stent neoatherosclerosis in lesions with more than 50% neointimal cross-sectional area stenosis.
    Lee SY; Shin DH; Mintz GS; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
    EuroIntervention; 2013 Dec; 9(8):945-51. PubMed ID: 24384291
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intravascular imaging analysis of a drug-eluting balloon followed by a bare metal stent compared to a drug-eluting stent for treatment of de novo lesions.
    Choi W; Chae IH; Park JJ; Kim SH; Kang SH; Oh IY; Yoon CH; Cho YS; Youn TJ; Choi DJ
    Korean J Intern Med; 2019 Jul; 34(4):819-829. PubMed ID: 29961306
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tissue characterization after drug-eluting stent implantation using optical coherence tomography.
    Malle C; Tada T; Steigerwald K; Ughi GJ; Schuster T; Nakano M; Massberg S; Jehle J; Guagliumi G; Kastrati A; Virmani R; Byrne RA; Joner M
    Arterioscler Thromb Vasc Biol; 2013 Jun; 33(6):1376-83. PubMed ID: 23539216
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neointimal tissue characterization after implantation of drug-eluting stents by optical coherence tomography: quantitative analysis of optical density.
    Nishino S; Sakuma M; Kanaya T; Nasuno T; Tokura M; Toyoda S; Abe S; Nakamura D; Tanaka K; Attizzani GF; Bezerra HG; Costa MA; Inoue T
    Int J Cardiovasc Imaging; 2019 Nov; 35(11):1971-1978. PubMed ID: 31218524
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of neointimal morphology of lesions with or without in-stent restenosis: an optical coherence tomography study.
    Lee SJ; Kim BK; Kim JS; Ko YG; Choi D; Jang Y; Hong MK
    Clin Cardiol; 2011 Oct; 34(10):633-9. PubMed ID: 21928365
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stent coverage and neointimal proliferation in bare metal stents postdilated with a Paclitaxel-eluting balloon versus everolimus-eluting stents: prospective randomized study using optical coherence tomography at 6-month follow-up.
    Poerner TC; Otto S; Gassdorf J; Nitsche K; Janiak F; Scheller B; Goebel B; Jung C; Figulla HR
    Circ Cardiovasc Interv; 2014 Dec; 7(6):760-7. PubMed ID: 25371536
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Difference of neointimal growth patterns in bifurcation lesions among four kinds of drug-eluting stents: an optical coherence tomographic study.
    Yoshimura T; Tanaka A; Mori N; Nakamura D; Taniike M; Makino N; Egami Y; Shutta R; Tanouchi J; Nishino M
    Catheter Cardiovasc Interv; 2014 Nov; 84(5):742-9. PubMed ID: 24497273
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serial changes of neointimal tissue after everolimus-eluting stent implantation in porcine coronary artery: an optical coherence tomography analysis.
    Won H; Kim JS; Shin DH; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
    Biomed Res Int; 2014; 2014():851676. PubMed ID: 25309929
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serial Optical Coherence Tomography Evaluation at 6, 12, and 24 Months After Biolimus A9-Eluting Biodegradable Polymer-Coated Stent Implantation.
    Konishi A; Shinke T; Otake H; Takaya T; Osue T; Kinutani H; Kuroda M; Takahashi H; Terashita D; Shite J; Hirata K
    Can J Cardiol; 2015 Aug; 31(8):980-8. PubMed ID: 26117623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.